These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14984453)

  • 1. The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart.
    Ceriello A; Cavarape A; Martinelli L; Da Ros R; Marra G; Quagliaro L; Piconi L; Assaloni R; Motz E
    Diabet Med; 2004 Feb; 21(2):171-5. PubMed ID: 14984453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
    Beisswenger PJ; Brown WV; Ceriello A; Le NA; Goldberg RB; Cooke JP; Robbins DC; Sarwat S; Yuan H; Jones CA; Tan MH;
    Diabet Med; 2011 Sep; 28(9):1088-95. PubMed ID: 21517955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.
    Gallagher A; Butler TJ; Home PD
    Diabetes Res Clin Pract; 2007 Jun; 76(3):327-34. PubMed ID: 17092597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prandial Insulins: A Person-Centered Choice.
    Attri B; Nagendra L; Dutta D; Shetty S; Shaikh S; Kalra S; Bhattacharya S
    Curr Diab Rep; 2024 Jun; 24(6):131-145. PubMed ID: 38568467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.
    Perriello G; Pampanelli S; Porcellati F; Avogaro A; Bosi E; Petrella G; Squatrito S; Furneri S; Marra G; Vitali L; Previti M; Cucinotta D
    Diabet Med; 2005 May; 22(5):606-11. PubMed ID: 15842516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus.
    Brunner GA; Hirschberger S; Sendlhofer G; Wutte A; Ellmerer M; Balent B; Schaupp L; Krejs GJ; Pieber TR
    Diabet Med; 2000 May; 17(5):371-5. PubMed ID: 10872536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test.
    Mori Y; Kuriyama G; Tajima N
    Endocrine; 2004 Dec; 25(3):203-6. PubMed ID: 15758246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
    Schmoelzer I; de Campo A; Pressl H; Stelzl H; Dittrich P; Oettl K; Wascher TC
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):176-81. PubMed ID: 15789278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hyperglycemia in nitrotyrosine postprandial generation.
    Ceriello A; Quagliaro L; Catone B; Pascon R; Piazzola M; Bais B; Marra G; Tonutti L; Taboga C; Motz E
    Diabetes Care; 2002 Aug; 25(8):1439-43. PubMed ID: 12145247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus.
    Evans M; Anderson RA; Smith JC; Khan N; Graham JM; Thomas AW; Morris K; Deely D; Frenneaux MP; Davies JS; Rees A
    Eur J Clin Invest; 2003 Mar; 33(3):231-8. PubMed ID: 12641541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K; Colombo M; Storgaard H; ØStergaard A; Kølendorf K; Madsbad S
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-prandial hyperglycaemia--the necessity for better control.
    Del Prato S
    Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of insulin aspart in patients with type 2 diabetes: assessment using a meal tolerance test under clinical conditions.
    Ando H; Kurita S; Shimizu A; Kato K; Ishikura K; Taji K; Uno M; Takeshita Y; Misu H; Fujimura A; Kaneko S; Takamura T
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):528-34. PubMed ID: 22642657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.
    Fysekidis M; Cosson E; Takbou K; Sutton A; Charnaux N; Banu I; Vicaut E; Valensi P
    Microvasc Res; 2018 Mar; 116():6-14. PubMed ID: 28954218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.
    Tan KC; Tso AW; Tam SC; Pang RW; Lam KS
    Diabet Med; 2002 Nov; 19(11):944-8. PubMed ID: 12421432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.